AGP Picks
View all

Central Europe Online : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .

Press releases published on July 1, 2026

WhiteBIT Introduces TradeFi as Demand Grows for Multi-Asset Trading
Surventis launches as an independent global leader in automotive coatings and surface treatment
North America Mobility as a Service Market to Reach US$ 217.0 Bn by 2033, Growing at a CAGR of 21.4% During 2026–2033
Lumenloop Report Warns MEES Retrofit Push Could Add to UK’s 5.2m-a-Year Lighting Waste Problem
Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer
Top Gas Furnace Manufacturer Strengthens Industrial Heating Innovation Through Advanced Engineering
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
A Fourth of July Letter from CoinShares to Our American Shareholders
Breaking: As QuantRate Launches Its Free AI Trading Bot, the AI Investing Trend Accelerates the Transformation of Global Financial Markets
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Kyivstar Subsidiary Uklon Launches Visa Acceptance Platform, Strengthening Digital Payments Infrastructure in Ukraine
Creative Medical Technology Holdings Issues Mid-Year Update
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Central Europe Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.